Adapting Appetites - Scientific and Industry Perspectives on the Rise of GLP-1 Medications
14 Oct 2025 | Kerry Health and Nutrition Institute
As the adoption of GLP-1 Receptor Agonists (GLP-1 RAs) rapidly accelerates, the food and beverage industry stands at the threshold of significant transformation. These breakthrough medications are reshaping not only individual health journeys but also consumer preferences and expectations. In response, manufacturers, product innovators, and nutrition professionals are urgently re-examining how to support evolving dietary patterns, nutritional needs, and purchasing behaviours.

Angie Jefferson
Nutrition Consultant

Dr Alexandra Boelrijk
VP Research and Development ProActive Health Food Protection and Preservation

Elizabeth Horvath
Vice President Marketing North America

Angie Jefferson
Nutrition Consultant

Dr Alexandra Boelrijk
VP Research and Development ProActive Health Food Protection and Preservation

Elizabeth Horvath
Vice President Marketing North America
Mark Faherty
Senior Director External Corporate Affairs

Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Mark Faherty
Senior Director External Corporate Affairs

Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre

Angie Jefferson
Nutrition Consultant

Dr Alexandra Boelrijk
VP Research and Development ProActive Health Food Protection and Preservation

Elizabeth Horvath
Vice President Marketing North America
Mark Faherty
Senior Director External Corporate Affairs

Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder















